Short description
Guide Therapeutics is a biotechnology company solving the challenge of delivery of genetic therapies.
Description
Guide Therapeutics is a biotechnology company that solves the challenge of delivery of genetic therapies. The company patented technologies to test thousands of chemically distinct nanoparticles in vivo. This enables them to identify simple, scalable, and clinically relevant nanoparticles that target new cell types efficiently and safely. It pioneers new gene therapies by developing field-leading drug delivery vehicles.
Guide Therapeutics is using a proprietary screening platform that performs thousands of drug delivery experiments directly in vivo, they identify nanoparticles that deliver DNA or RNA to cell types others cannot reach.
Last funding
Noaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Tucker, Georgia, United States, North America
Founded on
January 1, 2018
Exited on
February 23, 2021
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$1230 - 4560
Sign in for full access
Investors
Noaccess
Sign in for full access
Founders
Cory Sago, James Dahlman